RecruitingPhase 2Phase 3NCT06050148

Faecal Microbiota Transplantation as Means of Preventing Recurrent Urinary Tract Infections

Sponsor

Helsinki University Central Hospital

Enrollment

100 participants

Start Date

Aug 1, 2023

Study Type

INTERVENTIONAL

Conditions

recurrent urinary tract infection

Summary

This study investigates Faecal microbiota transplantation (FMT) in prevention of recurrent urinary tract infections (UTIs) caused either by sensitive E. coli or ESBL-E. coli.

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a biological treatment called Feacal microbial transplantation (FMT) and Placebo transplantation (PT) for people with recurrent urinary tract infection. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 90 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.